Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation: 26/08/2021, Revision: 12, Status: Authorised

Paediatric Committee (PDCO): 27-30 January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 January 2026 to 30 January 2026

Agenda - PDCO agenda of the 27-30 January 2026 meeting

Scientific Advisory Group on Vaccines and Therapies for Infectious Diseases (SAG-V&ID)

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 19, Status: Authorised

PSUSA/00011084/202503

Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 31, Status: Authorised

Avian influenza (bird flu)